-
New Chair, Heidi Rehm, on the Future Focus of the Global Alliance for Genomics and Health
Bio-IT World | In January, Heidi Rehm will take over the leadership of the Global Alliance for Genomics and Health, GA4GH, replacing out-going Chair Ewan Birney. Rehm sat down with Stan Gloss to talk about the mission of GA4GH and share areas of future focus for the latest episode of the Trends from the Trenches podcast.
Oct 31, 2023
-
Enkelejda Miho on Curiosity, Courage, and Advancing Research With Adisciplinary Approaches
Bio-IT World | In the latest episode of The Chain podcast, host Ben Hackel, Professor of Chemical Engineering & Materials Science at the University of Minnesota, speaks with Enkelejda “Ledi” Miho, Professor of Digital Life Sciences at the University of Applied Sciences Northwestern Switzerland FHNW, about the data challenges currently facing drug discovery, and how an adisciplinary approach would allow a more fruitful flow of ideas between indication silos, fueling discovery.
Oct 27, 2023
-
NTT Corporation Joins Japan Precision Medicine Platform Project, FDA Gives Grant To Aspen Neuroscience, Cancer Research Horizons And Genialis Team Up
Bio-IT World | NTT Corporation joins an agreement with BC Platforms AG, PRIME-R, and Bioxcellerator to develop the Japan Precision Medicine Platform (JPP), a secure information sharing platform for medical data designed to improve medical data analysis and medical research domestically across Japan; FDA grants Fast Track Designation for Aspen Neurosciencce Parkinson's disease treatment; Genialis announces a new data-sharing collaboration with Cancer Research Horizons to better predict responses to KRAS inhibitors, immunotherapies, and other emerging classes of therapeutics; and more.
Oct 26, 2023
-
Follow the Money: Generative AI, bioMérieux Expands Oxford Nanopore Investment, Radiopharmaceuticals Development, More
Bio-IT World | bioMérieux further invests in Oxford Nanopore’s in vitro diagnostics; Automata Technologies raises funds for lab automation; NVIDIA and others invest in Iambic Therapeutics (formerly Entos) for generative AI; and more.
Oct 25, 2023
-
A Shift Toward Multiomics: How Genome Sequencing is Improving Human Health
Bio-IT World| There has perhaps never been a more exciting time to work in genetics. Thanks to technological advances and information sharing through various industry and academic collaborations, we know more today about the human genome and how it influences human health than could have ever been previously imagined.
Oct 20, 2023
-
Multi-Lab Preclinical Model Aims To Solve The Reproducibility Crisis
Bio-IT World| A new preclinical system put to the test by a network of labs to adaptively study a handful of stroke treatments has succeeded in demonstrating that high-quality science is “feasible, practical, and less expensive than doing things the wrong way.”
Oct 18, 2023
-
Illumina Ordered To Unwind Acquisition Of GRAIL
Bio-IT World| The European Commission (EC), under the EU Merger Regulation (EUMR), released a statement last week announcing it has taken restorative measures that require Illumina to unwind its acquisition of GRAIL. The acquisition was completed before the EC provided approval, breaching EU merger control rules.
Oct 16, 2023
-
Navigating the Data-Rich Landscape of Healthcare: The Utility of Data Exploration and Visualization
Bio-IT World| In the ever-expanding universe of real world data, exploration and visualization strategies have become indispensable. This article presents 5 takeaways relevant to these strategies.
Oct 13, 2023
-
Low-Bass Music Controls Insulin Release From Designer Cells
Bio-IT World| Scientists in Switzerland have figured out how to remotely control genes in a way that could one day enable diabetics to produce and administer insulin directly in their body rather than relying on injections, inhalers, and pumps. Low-bass heavy popular music and movie soundtracks are being used to trigger insulin release from designer cells in implantable capsules when intentionally directed at the implant site.
Oct 11, 2023
-
Proteomics Enables Vastly Improved Cardiovascular Disease Prediction
Bio-IT World| The rise and fall of blood protein levels over time is an astonishingly good way to assess the risk of major atherosclerotic cardiovascular disease (ASCVD) events such as myocardial infarction (heart attack), as well as an ideal biomarker of the progression of disease and its regression in response to treatment.
Oct 10, 2023
-
Children’s Mercy Brings Long Read Sequencing to Clinical Care
Bio-IT World Beginning today, the research team at Children’s Mercy Kansas City is bringing long read sequencing to clinical care, following three years of research and testing of PacBio HiFi sequencing. The transition is expected to speed the diagnostics odyssey for critically ill patients and their families.
Oct 6, 2023
-
Synthace’s ‘Design of Experiments’ Approach Enables Multi-Factorial Wet Lab Experiments
Bio-IT World| INNOVATIVE PRACTICES AWARDS—Cultured meat may not be the standard use case for a Bio-IT World Innovative Practices Award, but the entry from Higher Steaks and Synthace caught the judges’ attention less for its application as for the innovation in experimental design.
Oct 4, 2023
-
Bio-IT World Issues 2024 Innovative Practices Awards Call for Entries
Bio-IT World| Bio-IT World is accepting entries for the 2024 Innovative Practices Awards, a competition designed to recognize the most exciting partnerships and projects pushing the life sciences industry forward.
Oct 3, 2023
-
Chan Zuckerberg Life Sciences Computing System, Microsoft and Paige AI Partnership, Rehm Takes Chair of GA4GH
Bio-IT World| Paige and Microsoft aim to build the world’s largest image-based AI models for digital pathology and oncology; Flatiron Health and FDA partner; HHS extends partnership with Regeneron; the GA4GH Board of Directors has elected Heidi Rehm to succeed Ewan Birney; and more.
Sep 28, 2023
-
Follow the Money: NIH Establishes “Multi-Omics” Data Research Center, Huge Funding for Advancing AI Platform
Bio-IT World| Moderna and Immatics launch a strategic research and development collaboration to pioneer novel and transformative therapies for cancer patients with high unmet medical need; The National Institutes of Health is establishing the Multi-Omics for Health and Disease Consortium to advance the generation and analysis of “multi-omic” data for human health research; Generate:Biomedicines has secured huge funding to advance its AI platform used to increase precision, speed, and probability of success of novel therapeutics; more.
Sep 27, 2023
-
The Why, How, and Hope of Generative AI and Data Technology With Bryn Roberts
Bio-IT World| As artificial intelligence continues to rapidly develop, it is tempting for organizations to rush into using AI—or at least an AI buzzword. In the latest episode of the Trends from the Trenches podcast, host Stan Gloss channels Simon Sinek and challenges Bryn Roberts to start with why.
Sep 26, 2023
-
Proteomics-Based Assays To Enable Precision Medicine For Ovarian Cancer
Bio-IT World | Over 900 genes have been implicated in the resistance of tumors to platinum-based chemotherapy that map to many different cellular pathways, thwarting efforts to identify a biomarker to predict refractoriness.
Sep 21, 2023
-
Study Ties Body Mass Index To Size Of The Hypothalamus
Bio-IT World | The brain structure of people with higher body mass index (BMI) looks quite different than individuals of a healthy weight, based on MRI scans of their hypothalamus analyzed with a recently developed machine learning algorithm.
Sep 20, 2023
-
City of Hope’s Harmonized, Findable, Accessible Precision Medicine Data Platform
Bio-IT World | INNOVATIVE PRACTICES AWARDS—When City of Hope wanted to better use its primary and secondary clinical research data and harmonize files on more than 700,000 patients so they were findable and accessible, the hospital built a highly scalable, compliant cloud-based platform.
Sep 19, 2023
-
Cross-Department Collaboration Reveals Business Intelligence Already On Hand
Bio-IT World | INNOVATIVE PRACTICES AWARDS—There are questions every research group could ask. At Regeneron’s Research and Preclinical department, tackling these questions meant accounting for more than 2,000 expensive and space-constrained instruments and seeking insight into how they are used.
Sep 14, 2023